BBGBloomberg·2hBusiness
score+0.60
Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO
Original
Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO
“IPO fundraising framed constructively with emphasis on company backing, capital raise scale, and unmet medical need addressing.”